uk 68798 has been researched along with silodosin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chen, Y; Guo, D; Jiang, H; Li, H; Li, J; Lin, H; Liu, H; Shan, L; Shoichet, BK; Sun, H; Xie, X; Zhang, D; Zhang, W; Zhao, F; Zhou, Y | 1 |
1 review(s) available for uk 68798 and silodosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for uk 68798 and silodosin
| Article | Year |
|---|---|
Design, Synthesis, and Biological Evaluation of Novel Tetrahydroprotoberberine Derivatives (THPBs) as Selective α
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Berberine Alkaloids; Dose-Response Relationship, Drug; Drug Design; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Male; Mice; Mice, Inbred Strains; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship; Tumor Cells, Cultured | 2016 |